SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-047514
Filing Date
2015-08-10
Accepted
2015-08-10 07:24:09
Documents
5
Period of Report
2015-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v417662_8k.htm 8-K 30265
2 EXHIBIT 2.1 v417662_ex2-1.htm EX-2.1 272062
3 EXHIBIT 10.1 v417662_ex10-1.htm EX-10.1 64851
4 EXHIBIT 99.1 v417662_ex99-1.htm EX-99.1 30387
5 GRAPHIC image_001.jpg GRAPHIC 42764
  Complete submission text file 0001144204-15-047514.txt   457762
Mailing Address 100 CLEARBROOK ROAD ELMSFORD NY 10523
Business Address 100 CLEARBROOK ROAD ELMSFORD NY 10523 914 460 1600
BioScrip, Inc. (Filer) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28740 | Film No.: 151039189
SIC: 5912 Retail-Drug Stores and Proprietary Stores